Subscribe To
Novo nordisk (nvo) q4 earnings beat estimates, revenues miss
Novo Nordisk (NVO) reports mixed results for Q4 as earnings beat estimates but sales miss on the same. Sales are aided by growth in Diabetes and ...
February 1, 2023, 3:03 pm
Novo nordisk sees obesity drug fueling record profit
Novo Nordisk President and Chief Executive Officer Lars Fruergaard Jorgensen discusses soaring demand for the company's ...
February 1, 2023, 5:18 am
Novo nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Danish pharmaceutical company Novo Nordisk AS DK:NOVO.B NVO on Wednesday raised its dividend and launched a new 28 billion Danish kroner ($4.09 billio...
February 1, 2023, 2:25 am
Cardiac implantable electronic device market to reach us$ 16.1 billion by end of 2031, reveals transparency market research, inc.
Manufacturers focus on reducing the size of implantable devices to gain a competitive edge Wilmington, Delaware, United States, Jan. 18, 2023 (GLOBE N...
January 17, 2023, 6:30 pm
Gamma knife market holds a worth of us$ 343.1 mn as of 2023, and by 2033, it is estimated to reach a revenue of us$ 600 mn at cagr of 5.7% during forecast period of 2023-33 | future market insights, i
Rising obesity Cases to Increase the Valuation of Gamma Knife Market to US$ 600 Million by 2033: FMI Pr...
December 26, 2022, 9:00 am
Gamma knife market holds a worth of us$ 343.1 mn as of 2023, and by 2033, it is estimated to reach a revenue of us$ 600 mn at cagr of 5.7% during forecast period of 2023-33 | future market insights, i
Rising obesity Cases to Increase the Valuation of Gamma Knife Market to US$ 600 Million by 2033: FMI Pr...
December 26, 2022, 9:00 am
Gamma knife market holds a worth of us$ 343.1 mn as of 2023, and by 2033, it is estimated to reach a revenue of us$ 600 mn at cagr of 5.7% during forecast period of 2023-33 | future market insights, i
Rising obesity Cases to Increase the Valuation of Gamma Knife Market to US$ 600 Million by 2033: FMI Pr...
December 26, 2022, 9:00 am
Gamma knife market holds a worth of us$ 343.1 mn as of 2023, and by 2033, it is estimated to reach a revenue of us$ 600 mn at cagr of 5.7% during forecast period of 2023-33 | future market insights, i
Rising obesity Cases to Increase the Valuation of Gamma Knife Market to US$ 600 Million by 2033: FMI Pr...
December 26, 2022, 9:00 am
Terns announces closing of public offering of shares of common stock, including full exercise of underwriters’ option to purchase additional shares
FOSTER CITY, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
December 23, 2022, 9:05 pm
Terns announces pricing of $75 million public offering
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
December 21, 2022, 12:40 am
Poolbeg pharma targets first half of next year for first trial of oral diabetes/anti-obesity drug
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has exclusively licensed specialist microencapsulation or nanoencapsulation developed by a company...
December 14, 2022, 2:40 am
The bullish call eli lilly made for its next-gen obesity drug, a rival to novo, amgen
Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testi...
December 13, 2022, 12:28 pm
Eli lilly sets guidance for 2023 and stock falls as eps lags current consensus
Eli Lilly & Co. LLY, +1.73% announced guidance for 2023 on Tuesday and highlighted potential launches for a series of treatments, including a potentia...
December 13, 2022, 6:54 am
Amgen is the underdog in obesity treatment — but it's creeping up on novo nordisk, eli lilly
Amgen stock could get a fresh boost Thursday after the company unveiled promising results for its obesity...
December 1, 2022, 9:30 am
Galectin therapeutics to present at 6th obesity & nash drug development summit
NORCROSS, Ga., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin...
November 28, 2022, 8:00 am
Gold coast keto gummies maggie beer australia reviews shocking shark tank exposed must read feedback and price?
This diet is not just about losing those fatty molecules from your body but also reducing the risk of many health issues caused by ...
November 19, 2022, 7:33 pm
Abercrombie deletes ad after tweetstorm over ‘normalizing' obesity
Abercrombie & Fitch has deleted an ad featuring a plus-sized woman that went viral on social media and ignited a debate on whether the retail company ...
August 29, 2022, 12:06 pm
Novo nordisk: assessing hype towards obesity care following the q2 results drop, story is intact
A true compounder, Novo Nordisk is positioning itself beyond basal insulin amid market and government pressures. Crucial to this strategy is its fledg...
August 23, 2022, 5:57 pm
Novo nordisk ceo on treating diabetes and obesity, and challenges facing the industry
Novo Nordisk CEO Lars Jorgensen discusses the company's latest results, developing and supplying the world with medication and devices to treat diabet...
August 4, 2022, 9:09 am
obesity drug supply delay not unusual says novo nordisk ceo
Novo Nordisk sought to soothe concerns about supplies of its new obesity drug Wegovy on Thursday, sayin...
August 4, 2022, 5:40 am